Investors

Key Figures

EUR 1,000, unaudited	2023	2022	2021	2020	2019	2018
Net sales	3,906.2	2,941.9	2,002.9	1,499.3	1,746.5	1,585.0
Sales margin	2,810.6	2,138.8	1,376.0	1,102.6	1,250.6	1,097.4
Sales margin, %	71.9%	72.7%	68.7%	73.5%	71.6%	69.2%
EBITDA	-2,833.1	-2,112.0	-2,496.8	-1,786.6	-1,606.2	-1,566.2
EBIT	-3,033.8	-2,291.7	-2,665.9	-1,924.8	-1,737.4	-1,602.0
Net profit (loss)	-3,788.6	-2,416.2	-6,016.5	-2,258.8	-1,734.9	-2,054.0
R&D spend on total costs, %	25.6%	28.1%	34.7%	23.6%	17.3%	14.1%
Equity ratio, %	77.3%	55.2%	50.6%	35.1%	-77.3%	1.4%
Cash and cash equivalents	6,910	1,223	6,621	2,273	58	1,232
Personnel at the end of the period	37	28	26	23	23	21

Definitions of key figures

Key figure	Calculation formula
Sales margin	Revenue + other operating income - change in inventories - materials and services
Sales margin, %	(Sales margin / Revenue) x 100
EBITDA	Revenue + other operating income – change in inventories – materials and services -personnel expenses – other operating expenses
EBIT	Revenue + other operating income – change in inventories – materials and services -personnel expenses – other operating expenses – depreciation and amortization
Net profit (loss)	Revenue + other operating income – change in inventories – materials and services -personnel expenses – other operating expenses – depreciation and amortization – net financial expenses – income taxes
RD spend on total costs, %	Research and development expenses / (personnel expenses + depreciation + other operating expenses) x 100
Equity ratio, %	Total equity at the end of the period / (Total liabilities at the end of the period- advances received at the end of the period) x 100
Cash and cash equivalents	Cash and cash equivalents including money market deposits at the end of the period